TransMedics (TMDX) Gains from Investment Securities (2018 - 2019)
TransMedics (TMDX) posted Gains from Investment Securities of $614000.0 for Q2 2019, up 324.91% on a QoQ basis from -$273000.0 in Q1 2019, and up 192.38% year-over-year from $210000.0 in Q2 2018.
Powered by 
Analysis
TransMedics (TMDX) Gains from Investment Securities (2018 - 2019) Analysis & Trends
TransMedics has reported Gains from Investment Securities for 2 years, with the latest figure at $614000.0 in Q2 2019.
- On a quarterly basis, Gains from Investment Securities rose 192.38% year-over-year to $614000.0 in Q2 2019; TTM through Mar 2020 was $614000.0, a 153.72% increase from a year earlier, with the FY2022 full-year figure at $107000.0, changed N/A from the prior year.
- Gains from Investment Securities was $614000.0 for Q2 2019 at TransMedics, up from -$273000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $614000.0 in Q2 2019, with the low at -$273000.0 in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | TransMedics | 3.12 Bn | 2.64 Bn | 113.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 29, 2019 | 614,000.00 |
| Mar 30, 2019 | -273,000.00 |
| Dec 29, 2018 | 122,000.00 |
| Sep 29, 2018 | 183,000.00 |
| Jun 30, 2018 | 210,000.00 |
| Mar 31, 2018 | 30,000.00 |